The HLDA8 blind panel: Findings and conclusions
Bernadette Swart(Women's & Children's Health Research Institute), Heddy Zola(Women's & Children's Health Research Institute), M. P. Wand(University of Technology Sydney), Greg Hodge(Women's and Children's Hospital), Kathryn Tinckam(Brigham and Women's Hospital), Václav Hořejšı́(Czech Academy of Sciences, Institute of Molecular Genetics), Debbrah J. Millard(Women's and Children's Hospital), M.P. Salganik(Harvard University), Karel Drbal(Czech Academy of Sciences, Institute of Molecular Genetics), Attila Dağdeviren(Hacettepe University), Sheree Bailey(University of South Australia), Judith Nairn(Women's and Children's Hospital), Geoffrey W. Dandie(Women's and Children's Hospital), Edgar L. Milford(Brigham and Women's Hospital), Peter J. Macardle(Flinders Medical Centre), Pavla Angelisová(Czech Academy of Sciences, Institute of Molecular Genetics), Enoc Hollemweguer(Becton Dickinson (United States))
Cited by 4
Related Papers
Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report
|American Journal of Transplantation|2018|291
Adverse Outcomes of Tacrolimus Withdrawal in Immune–Quiescent Kidney Transplant Recipients
|Journal of the American Society of Nephrology|2015|193
The APOL1 Genotype of African American Kidney Transplant Recipients Does Not Impact 5-Year Allograft Survival
|American Journal of Transplantation|2012|182
CD molecules 2006 — Human cell differentiation molecules
|Journal of Immunological Methods|2006|164
Antibody‐Functionalized Porous Silicon Nanoparticles for Vectorization of Hydrophobic Drugs
|Advanced Healthcare Materials|2012|130